Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia

NCT00801619 | Completed DMC

• 1 other identifier: 2006P001624
• Study Type: observational
• Target: 273
• Locations: 1 country
• Sites: 1

Brief Summary

We will use information technology to integrate the 2004 American Academy of Pediatrics guidelines for management of neonatal hyperbilirubinemia with laboratory reporting of newborn bilirubin test results to improve physician adherence to the guidelines and quality of care.

Conditions

Neonatal Hyperbilirubinemia

Outcome Measures

Primary Outcomes (1)

• Adherence to clinical guidelines

  Adeherence to AAP clinical guidelines in treating neonatal hyperbilirubinemia

  Initial Newborn Inpatient Stay, which on average is 2-3 days in length

Study Arms (2)

Intervention

Receive decision support when reviewing bilirubin results in the clinical information systems/electronic health record

Control

No decision support

Eligibility Criteria

• Age: Up to 1 Month
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

Providers who care for infants in the newborn nursery at MGH will be study eligible. All newborns 35 weeks or more weeks of gestation will be study eligible.

You may qualify if:

• Providers who care for infants in the newborn nursery.
• All newborns in the newborn nursery that are 35 weeks or more weeks of gestation will be study eligible.

You may not qualify if:

• Infants less than 35 weeks gestation.

Sponsors & Collaborators

• Massachusetts General Hospital: lead

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (1)

• American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004 Jul;114(1):297-316. doi: 10.1542/peds.114.1.297.

  PMID: 15231951 BACKGROUND

MeSH Terms

Conditions

Hyperbilirubinemia, Neonatal

Condition Hierarchy (Ancestors)

Infant, Newborn, Diseases; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hyperbilirubinemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• John Patrick T Co, MD, MPH

  Massachusetts General Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 2, 2008
• First Posted: December 3, 2008
• Study Start: November 1, 2008
• Primary Completion: December 1, 2011
• Study Completion: December 1, 2011
• Last Updated: March 16, 2016

Record last verified: 2016-03

Locations

US (1)